Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: A cohort study

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Coelho, Luís M ^a,b   Salluh, Jorge I F ^c,d,e,f   Soares, Márcio ^c,d,e,f   Bozza, Fernando A ^g,h   Verdeal, Juan Carlos R ^h,i   Castro Faria Neto, Hugo C ^h,j   Lapa e Silva, José R ^k,l   Bozza, Patrícia T ^j   Póvoa, Pedro ^a,b  

^a HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^d Rua Diniz Cordeiro   (Brazil)

^e INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^f Instituto Federal de Educação   (Brazil)

^g Funda??o Oswaldo Cruz   (Brazil)

^h Ilha Cidade Universitária Cidade Universitária ^*  (Brazil)

ⁱ Hospital Barra D'Or   (Brazil)

^j INSTITUTO OSWALDO CRUZ   (Brazil)

^k FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^l Ilha Cidade Universitária Cidade Universitária   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVOR; TREATMENT RESPONSE; APACHE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; APACHE; BIOMARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858738850     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11291     Document Type: Article

References (24)

1. Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, Bartolome M, Balanzo X. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000, 15:757-763. 10.1034/j.1399-3003.2000.15d21.x, 10780770.
2. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008, 133:610-617. 10.1378/chest.07-1456, 17989157.
3. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996, 275:134-141. 10.1001/jama.1996.03530260048030, 8531309.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Eng J Med 1997, 336:243-250.
5. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003, 31:676-682. 10.1097/01.CCM.0000055380.86458.1E, 12626968.
6. Wunderink RG, Laterre PF, Francois B, Perrotin D, Artigas A, Vidal LO, Lobo SM, Juan JS, Hwang SC, Dugernier T, LaRosa S, Wittebole X, Dhainaut JF, Doig C, Mendelson MH, Zwingelstein C, Su G, Opal S. Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2011, 183:1561-1568. 10.1164/rccm.201007-1167OC, 21297074.
7. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005, 25:804-812. 10.1183/09031936.05.00071704, 15863636.
8. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005, 40:1855-1857. 10.1086/430382, 15909277.
9. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, Sabino H. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998, 24:1052-1056. 10.1007/s001340050715, 9840239.
10. Povoa P, Souza-Dantas VC, Soares M, Salluh JI. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care 2011, 15:R129. 10.1186/cc10242, 3218995, 21595932.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
12. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL, . American Thoracic Society Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754. American Thoracic Society.
13. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
14. Cox ML, Rudd AG, Gallimore R, Hodkinson HM, Pepys MB. Real-time measurement of serum C-reactive protein in the management of infection in the elderly. Age Ageing 1986, 15:257-266. 10.1093/ageing/15.5.257, 3776747.
15. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993, 91:1351-1357. 10.1172/JCI116336, 288106, 8473487.
16. Povoa P. Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Cur Opin Infect Dis 2008, 21:157-162.
17. Eisenhut M. A persistently elevated C-reactive protein level in pneumonia may indicate empyema. Crit Care 2008, 12:409. author reply 409, 2374620, 18341702.
18. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, Teixeira PJ. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006, 10:R125. 10.1186/cc5036, 1751074, 16956405.
19. Povoa PR, Teixeira-Pinto AM, Carneiro AH. C-reactive protein, an early marker of Community-Acquired Sepsis resolution: a multi-center prospective observational study. Crit Care 2011, 15:R169. 10.1186/cc10313, 21762483.
20. Moreno MS, Nietmann H, Matias CM, Lobo SM. C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect 2011, 61:205-211.
21. Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008, 36:166-171. 10.1097/01.CCM.0000297886.32564.CF, 18007271.
22. Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008, 32:726-732. 10.1183/09031936.00003608, 18508833.
23. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008, 121:219-225. 10.1016/j.amjmed.2007.10.033, 18328306.
24. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049. 10.1378/chest.123.6.2043, 12796187.